Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.
- NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_assertion description "[We hypothesize that genetic polymorphisms in metabolising enzymes gene GSTP1 (glutathione S-transferase P1), and MRP2 (multidrug resistance-associated protein 2) (ABCC2), which result in inter-individual differences in metabolism and drug disposition, may predict clinical response to platinum agents in advanced non-small cell lung cancer (NSCLC) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.
- NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_assertion evidence source_evidence_literature NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.
- NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_assertion SIO_000772 19568750 NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.
- NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_assertion wasDerivedFrom gad-20130706 NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.
- NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_assertion wasGeneratedBy ECO_0000203 NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.
- gad-20130706 importedOn "2013-07-06" NP42911.RAlfOhmxLDSae6ACyg3j6YoloRRJFu9jJFtQf1ZkmghfM130_provenance.